CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a ...
Compass Therapeutics (CMPX) stock was up 8% in afternoon trading Monday after Guggenheim initiated coverage of the stock with a buy rating ahead of upcoming data. Read more here.
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
Chinese technology stocks slumped as the country’s economy worsened. That changed when U.S. tariffs against China fell to ...
Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $145.00.
Ugur Sahin, the co-founder and CEO of BioNTech SE (BNTX), sold $119.58 million worth of the Germany-based biotechnology ...
Shares of Cloudflare shot up to $168.95 during today's afternoon trading session -- an increase of 19.4% that brings the stock 23.14% over its average analyst target price of $137.21. This may imply ...
One Gas, Inc. (NYSE: OGS) has announced the record date for its 2025 annual meeting of shareholders as March 24, 2025. The ...
The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, ...
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results